Complications of polyalkylimide 4% injections (Bio-Alcamid™):: a report of 18 cases

被引:52
作者
Karim, R. B.
Hage, J. J.
van Rozelaar, L.
Lange, C. A. H.
Raaijmakers, J.
机构
[1] Onze Lieve Vrouw Hosp, Dept Plast & Reconstruct Surg, NL-1090 HM Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Dept Plast & Reconstruct Surg, NL-1066 CX Amsterdam, Netherlands
[3] Med Laser Ctr, NL-1075 HN Amsterdam, Netherlands
[4] Onze Lieve Vrouw Hosp, Dept Radiol, NL-1090 HM Amsterdam, Netherlands
关键词
Bio-Alcamid (TM); complications; cosmetic; aesthetic; filler;
D O I
10.1016/j.bjps.2006.01.049
中图分类号
R61 [外科手术学];
学科分类号
摘要
Injectable fitter materials can be valuable to aesthetic surgeons. To date, hardly any short-term and no long-term complications of polyalkylimide injections (Bio-Atcamid(TM)) have been reported. We present and discuss the history of 18 patients who had such complications. The patients were between 31 and 55 years of age. The time between injection and the onset of complications of polyalkylimide ranged from 1 month to 3 years. Additional invasive therapy at, or near, the site of injections triggered the onset of infection in 10 patients. By use of T2-weighted MRI with fat suppressing spectro- presaturation inversion recovery (SPIR) the fitter material can be visualised. Once infection or migration of the permanent fitter occurs, the therapeutic options are limited to surgical removal by a direct approach. Polyalkylimide should be handled under strict antiseptic circumstances. This does not only apply at the time of initial injections, but even more during any subsequent invasive treatment such as evacuation of surplus deposits or additional surgical procedures at, or near, the site of injection. (c) 2006 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1409 / 1414
页数:6
相关论文
共 19 条
[2]  
Ascher B, 2004, Ann Chir Plast Esthet, V49, P465, DOI 10.1016/j.anplas.2004.09.001
[3]  
*BUND GES BER, 2002, SWISSMEDIC J, V1, P245
[4]   An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score [J].
Carr, A ;
Law, M .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (05) :571-576
[5]   Adverse reactions to injectable soft tissue permanent fillers [J].
Christensen, L ;
Breiting, V ;
Janssen, M ;
Vuust, J ;
Hogdall, E .
AESTHETIC PLASTIC SURGERY, 2005, 29 (01) :34-48
[6]   Chemical peels - Their place within the range of resurfacing techniques [J].
Fulton, JE ;
Porumb, S .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2004, 5 (03) :179-187
[7]   The devastating outcome of massive subcutaneous injection of highly viscous fluids in male-to-female transsexuals [J].
Hage, JJ ;
Kanhai, RCJ ;
Oen, AL ;
van Diest, PJ ;
Karim, RB .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 107 (03) :734-741
[8]   Human histology and persistence of various injectable filler substances for soft tissue augmentation [J].
Lemperle, G ;
Morhenn, V ;
Charrier, U .
AESTHETIC PLASTIC SURGERY, 2003, 27 (05) :354-366
[9]   A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds [J].
Lindqvist, C ;
Tveten, S ;
Bondevik, BE ;
Fagrell, D .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 115 (01) :282-289
[10]   Medical alert: Facial wrinkles - Injectable filler materials [J].
Maillard, GF .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 115 (01) :337-338